Chronic cough: Seeking the cause and the solution

Research output: Contribution to journalArticle

Abstract

In the vast majority of non-smokers who are not receiving angiotensin converting-enzyme inhibitors and who have no evidence of active disease on chest radiographs, chronic cough is caused by postnasal drip syndrome (recently renamed upper airway cough syndrome [UACS]), asthma, non-asthmatic eosinophilic bronchitis, or gastroesophageal reflux disease (GERD), alone or in combination. A high index of suspicion is required, because each of these conditions may present with cough as the sole symptom. Because UACS may be the most common cause of chronic cough, it appears reasonable to initially give empiric UACS therapy to patients in whom other causes are not evident at initial evaluation. In many cases, the combination of a first-generation antihistamine and a decongestant may be most effective. In general, the therapeutic approach to cough-variant asthma is similar to that of the typical form of asthma. Many patients have symptomatic improvement after 1 week of therapy with inhaled bronchodilators, but most will require inhaled corticosteroid therapy for full resolution of cough. Initial empiric therapy with a proton pump inhibitor and implementation of anti-reflux lifestyle measures may be appropriate for patients in whom GERD-induced cough is suspected.

Original languageEnglish (US)
Pages (from-to)130-143
Number of pages14
JournalConsultant
Volume48
Issue number2
StatePublished - Feb 2008

Fingerprint

Cough
Asthma
Gastroesophageal Reflux
Nasal Decongestants
Therapeutics
Bronchitis
Proton Pump Inhibitors
Histamine Antagonists
Bronchodilator Agents
Angiotensin-Converting Enzyme Inhibitors
Life Style
Adrenal Cortex Hormones
Thorax

Keywords

  • Asthma
  • Cough
  • Gastroesophageal reflux disease
  • Non-asthmatic eosinophilic bronchitis
  • Upper respiratory tract infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chronic cough : Seeking the cause and the solution. / Dicpinigaitis, Peter Vytautas; Alva, Rakesh V.

In: Consultant, Vol. 48, No. 2, 02.2008, p. 130-143.

Research output: Contribution to journalArticle

Dicpinigaitis, PV & Alva, RV 2008, 'Chronic cough: Seeking the cause and the solution', Consultant, vol. 48, no. 2, pp. 130-143.
Dicpinigaitis, Peter Vytautas ; Alva, Rakesh V. / Chronic cough : Seeking the cause and the solution. In: Consultant. 2008 ; Vol. 48, No. 2. pp. 130-143.
@article{fceafc4030d04e64aa312f3b685a4d91,
title = "Chronic cough: Seeking the cause and the solution",
abstract = "In the vast majority of non-smokers who are not receiving angiotensin converting-enzyme inhibitors and who have no evidence of active disease on chest radiographs, chronic cough is caused by postnasal drip syndrome (recently renamed upper airway cough syndrome [UACS]), asthma, non-asthmatic eosinophilic bronchitis, or gastroesophageal reflux disease (GERD), alone or in combination. A high index of suspicion is required, because each of these conditions may present with cough as the sole symptom. Because UACS may be the most common cause of chronic cough, it appears reasonable to initially give empiric UACS therapy to patients in whom other causes are not evident at initial evaluation. In many cases, the combination of a first-generation antihistamine and a decongestant may be most effective. In general, the therapeutic approach to cough-variant asthma is similar to that of the typical form of asthma. Many patients have symptomatic improvement after 1 week of therapy with inhaled bronchodilators, but most will require inhaled corticosteroid therapy for full resolution of cough. Initial empiric therapy with a proton pump inhibitor and implementation of anti-reflux lifestyle measures may be appropriate for patients in whom GERD-induced cough is suspected.",
keywords = "Asthma, Cough, Gastroesophageal reflux disease, Non-asthmatic eosinophilic bronchitis, Upper respiratory tract infection",
author = "Dicpinigaitis, {Peter Vytautas} and Alva, {Rakesh V.}",
year = "2008",
month = "2",
language = "English (US)",
volume = "48",
pages = "130--143",
journal = "Consultant",
issn = "0010-7069",
publisher = "Cliggott Publishing Co.",
number = "2",

}

TY - JOUR

T1 - Chronic cough

T2 - Seeking the cause and the solution

AU - Dicpinigaitis, Peter Vytautas

AU - Alva, Rakesh V.

PY - 2008/2

Y1 - 2008/2

N2 - In the vast majority of non-smokers who are not receiving angiotensin converting-enzyme inhibitors and who have no evidence of active disease on chest radiographs, chronic cough is caused by postnasal drip syndrome (recently renamed upper airway cough syndrome [UACS]), asthma, non-asthmatic eosinophilic bronchitis, or gastroesophageal reflux disease (GERD), alone or in combination. A high index of suspicion is required, because each of these conditions may present with cough as the sole symptom. Because UACS may be the most common cause of chronic cough, it appears reasonable to initially give empiric UACS therapy to patients in whom other causes are not evident at initial evaluation. In many cases, the combination of a first-generation antihistamine and a decongestant may be most effective. In general, the therapeutic approach to cough-variant asthma is similar to that of the typical form of asthma. Many patients have symptomatic improvement after 1 week of therapy with inhaled bronchodilators, but most will require inhaled corticosteroid therapy for full resolution of cough. Initial empiric therapy with a proton pump inhibitor and implementation of anti-reflux lifestyle measures may be appropriate for patients in whom GERD-induced cough is suspected.

AB - In the vast majority of non-smokers who are not receiving angiotensin converting-enzyme inhibitors and who have no evidence of active disease on chest radiographs, chronic cough is caused by postnasal drip syndrome (recently renamed upper airway cough syndrome [UACS]), asthma, non-asthmatic eosinophilic bronchitis, or gastroesophageal reflux disease (GERD), alone or in combination. A high index of suspicion is required, because each of these conditions may present with cough as the sole symptom. Because UACS may be the most common cause of chronic cough, it appears reasonable to initially give empiric UACS therapy to patients in whom other causes are not evident at initial evaluation. In many cases, the combination of a first-generation antihistamine and a decongestant may be most effective. In general, the therapeutic approach to cough-variant asthma is similar to that of the typical form of asthma. Many patients have symptomatic improvement after 1 week of therapy with inhaled bronchodilators, but most will require inhaled corticosteroid therapy for full resolution of cough. Initial empiric therapy with a proton pump inhibitor and implementation of anti-reflux lifestyle measures may be appropriate for patients in whom GERD-induced cough is suspected.

KW - Asthma

KW - Cough

KW - Gastroesophageal reflux disease

KW - Non-asthmatic eosinophilic bronchitis

KW - Upper respiratory tract infection

UR - http://www.scopus.com/inward/record.url?scp=40149085573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40149085573&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:40149085573

VL - 48

SP - 130

EP - 143

JO - Consultant

JF - Consultant

SN - 0010-7069

IS - 2

ER -